InvestorsHub Logo
Post# of 252199
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: oc631 post# 153001

Tuesday, 11/27/2012 4:20:29 AM

Tuesday, November 27, 2012 4:20:29 AM

Post# of 252199
PBTH

Two additional caveats:
Phillip Frost holds ~ 20% of the shares.
Phase II is really only a pilot study since (in addition to what you've mentioned) it was also short treatment (one month), patients weren't hGH-naïve, and primary endpoint was IGF-1 levels, these are not the conditions for the future phase III trial.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.